Markers and Mechanisms of Vascular Disease in Type II Diabetes

NCT00256646 · clinicaltrials.gov ↗

COMPLETED

Status

298

Enrollment

FED

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Rosiglitazone

Sponsor

US Department of Veterans Affairs

Collaborators

[object Object]